Alkermes PLC (ALKS)
24.06
-0.20
(-0.84%)
USD |
NASDAQ |
May 10, 16:00
24.06
0.00 (0.00%)
After-Hours: 19:20
Alkermes Revenue (TTM): 1.726B for March 31, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.726B |
| December 31, 2023 | 1.663B |
| September 30, 2023 | 1.591B |
| June 30, 2023 | 1.462B |
| March 31, 2023 | 1.121B |
| December 31, 2022 | 1.112B |
| September 30, 2022 | 1.132B |
| June 30, 2022 | 1.173B |
| March 31, 2022 | 1.201B |
| December 31, 2021 | 1.174B |
| September 30, 2021 | 1.129B |
| June 30, 2021 | 1.100B |
| March 31, 2021 | 1.044B |
| December 31, 2020 | 1.039B |
| September 30, 2020 | 1.171B |
| June 30, 2020 | 1.162B |
| March 31, 2020 | 1.194B |
| December 31, 2019 | 1.171B |
| September 30, 2019 | 1.074B |
| June 30, 2019 | 1.067B |
| March 31, 2019 | 1.092B |
| December 31, 2018 | 1.094B |
| September 30, 2018 | 1.054B |
| June 30, 2018 | 1.023B |
| March 31, 2018 | 936.75M |
| Date | Value |
|---|---|
| December 31, 2017 | 903.37M |
| September 30, 2017 | 841.52M |
| June 30, 2017 | 804.37M |
| March 31, 2017 | 780.70M |
| December 31, 2016 | 745.69M |
| September 30, 2016 | 695.28M |
| June 30, 2016 | 667.69M |
| March 31, 2016 | 623.90M |
| December 31, 2015 | 628.34M |
| September 30, 2015 | 640.40M |
| June 30, 2015 | 647.74M |
| March 31, 2015 | 649.79M |
| December 31, 2014 | 618.79M |
| September 30, 2014 | 583.43M |
| June 30, 2014 | 562.07M |
| March 31, 2014 | 572.07M |
| September 30, 2013 | 577.76M |
| June 30, 2013 | 561.94M |
| March 31, 2013 | 575.55M |
| December 31, 2012 | 542.60M |
| September 30, 2012 | 532.33M |
| June 30, 2012 | 480.33M |
| March 31, 2012 | 389.98M |
| December 31, 2011 | 310.64M |
| September 30, 2011 | 228.97M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
1.039B
Minimum
Dec 2020
1.726B
Maximum
Mar 2024
1.225B
Average
1.166B
Median
Revenue (TTM) Benchmarks
| Endo International PLC (DELISTED) | 2.012B |
| Jazz Pharmaceuticals PLC | 3.843B |
| Medtronic PLC | 32.32B |
| Perrigo Co PLC | 4.556B |
| Iterum Therapeutics PLC | -- |